NCT05634395

Brief Summary

GrannyFit is a prospective, national, multicenter, single-arm open-label study. It will include a total of 200 participants over the age of 70 years treated for de novo or recurrent (local or distant) BC. Participants will receive a Withing Steel activity tracker, which they will be asked to wear 24 h per day for 12 months. The principal assessments will be performed at baseline, at 6 months and at 12 months. The investigators will evaluate clinical (e.g. comorbidities), lifestyle, quality of life, fatigue, and physical activity parameters. All questionnaires will be completed on a REDCap form, via a secure internet link.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P50-P75 for not_applicable breast-cancer

Timeline
1mo left

Started Feb 2023

Typical duration for not_applicable breast-cancer

Geographic Reach
1 country

4 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress99%
Feb 2023May 2026

First Submitted

Initial submission to the registry

November 22, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 2, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

February 17, 2023

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 19, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 19, 2026

Last Updated

August 27, 2025

Status Verified

July 1, 2025

Enrollment Period

3.3 years

First QC Date

November 22, 2022

Last Update Submit

August 26, 2025

Conditions

Keywords

digitalactivity trackerlifestyleprevention

Outcome Measures

Primary Outcomes (3)

  • Describe physical activity profiles in breast cancer patients over 70 years of age

    The activity tracker will register step counts for each day. the investigators will plot the average daily step counts and the 95% confidence interval across the entire study period. Then will will study the change in step count trajectory during the study. Linear mixed model will be used for describing change over time

    Month 12

  • Describe sleep profiles in breast cancer patients over 70 years of age

    The activity tracker will register sleep duration for each day. The investigators will plot the average sleep duration and the 95% confidence interval across the entire study period. Then will tudy the change in sleep duration trajectory during the study. Linear mixed model will be used for describing change over time

    Month 12

  • Identify digital profiles (physical activity, sleep) in breast cancer patients over 70 years of age

    To identify digital profiles, the investigators will combine step counts profiles and sleep profiles using mixed models with latent classes. The use of a mixed model will make it possible to analyze repeat data for the population, and to determine an average profile or trajectory for the whole population. The optimal number of classes will be determined a posteriori, based on a set of statistical and clinical criteria. The most widely used statistical criterion is the "Bayesian information criterion" (BIC), which penalizes the model's likelihood according to its complexity. The BIC, which is stricter than many other criteria, has been shown to have a better performance in simulations. The number of trajectories will also be based on clinical interpretation (whether it is worthwhile retaining classes containing very small numbers of subjects, etc.).

    Month 12

Secondary Outcomes (7)

  • Analyze the effects of digital profiles on quality of life

    Month 6, Month 12

  • Analyze the effects of digital profiles on fatigue

    Month 6, Month 12

  • Analyze the effects of digital profiles on comorbidities

    Month 6, Month 12

  • Analyze the effects of digital profiles on significant life events

    Month 6, Month 12

  • Analyze the effects of digital profiles on physical activity

    Month 6, Month 12

  • +2 more secondary outcomes

Study Arms (1)

Intervention with activity tracker

EXPERIMENTAL

Women allocated to the intervention arm will used an activity tracker

Device: Activity tracker

Interventions

Participants will receive a Withings Steel activity tracker (Withings, Issy-les-Moulineaux, France), which they will be asked to wear 24 hours per day throughout the whole intervention (12 months). At baseline, the Withings Health Mate mobile phone application will be downloaded onto each participant's smartphone or tablet. The clinical research assistant will instruct the participant in the use of the activity tracker. The participant will then accept and activate the sharing of the data collected with the secure server dedicated to the "GrannyFit" study at the Institut Curie. Participants will be asked to synchronize the activity tracker regularly (ideally daily) via Bluetooth with the Withings Health Mate application, for automatic transfer of the data to the secure "GrannyFit" space.

Intervention with activity tracker

Eligibility Criteria

Age70 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Women over 70 years of age,
  • With histologically confirmed invasive breast cancer,
  • Regardless of histological subtype (hormone receptor positive (HR+), negative (HR-), with or without HER2 overexpression, or triple negative)
  • PS ≤ 2,
  • Willing and available to invest in the project for the duration of the study,
  • Using a personal smartphone or personal tablet compatible with the "Withings Health Mate" app (iOS 10/android 5.0 and later) and with an internet connection,
  • Affiliated with a social security plan,
  • Having dated and signed an informed consent,
  • Able to read, write and understand French.

You may not qualify if:

  • Presence of disabling metastases,
  • Moderate to severe cognitive impairment,
  • Persons deprived of liberty or under guardianship,
  • Inability to undergo the medical follow-up of the trial for geographical, social or psychological reasons,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Centre Léon Bérard

Lyon, 69008, France

Location

Institut Curie

Paris, 75005, France

Location

Institut GODINOT

Reims, 51100, France

Location

Institut Curie

Saint-Cloud, 92210, France

Location

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Fitness Trackers

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Diagnostic EquipmentEquipment and SuppliesWearable Electronic DevicesElectrical Equipment and Supplies

Study Officials

  • Fabien Reyal, MD

    Institut Curie

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 22, 2022

First Posted

December 2, 2022

Study Start

February 17, 2023

Primary Completion (Estimated)

May 19, 2026

Study Completion (Estimated)

May 19, 2026

Last Updated

August 27, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

Sponsor will share de-identified data sets. Documents generated under the project will be disseminated in accordance with Institut Curie policies.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Data requests can be submitted starting 9 months after last article publication and will be made accessible for up to 12 months.
Access Criteria
Access to trial individual participant data can be requested by qualified researchers engaging in independent scientific research, and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a data sharing agreement (DSA).

Locations